| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |